Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT07628088
Active, not recruiting Observational

AI-THEROSCOPE: AI Detection of Subclinical Atherosclerosis From Retinal Images

NCT07628088 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2023-10-01
Last updated
2026-06-10

Condition(s) studied

Subclinical AtherosclerosisCardiovascular Risk

Study summary

Cardiovascular risk scores are widely used for risk stratification but may fail to identify a substantial proportion of individuals with subclinical atherosclerosis who are at increased risk of future cardiovascular events. Vascular ultrasound can directly detect carotid and femoral atherosclerotic plaques but its implementation is limited by the need for trained operators and expert interpretation. The AI-THEROSCOPE study aims to develop and validate an artificial intelligence-based tool capable of detecting subclinical atherosclerosis through the analysis of non-mydriatic retinal fundus images. Participants undergo clinical assessment, laboratory testing, carotid and femoral ultrasound, and retinal fundus photography. The performance of the AI model will be evaluated against vascular ultrasound findings as the reference standard for the presence of subclinical atherosclerosis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 years or older. * No previous established cardiovascular disease. * Undergoing cardiovascular risk assessment and carotid and femoral vascular ultrasound. * Ability to provide written informed consent. Exclusion Criteria: * Previous acute coronary syndrome, stroke, or peripheral arterial disease. * Previous carotid or femoral vascular surgery or stenting. * Previous ophthalmologic surgery. * Retinal or ocular diseases that significantly affect retinal vasculature or image quality, including moderate or severe diabetic retinopathy, retinal vascular occlusion, advanced hypertensive retinopathy, exudative age-related macular degeneration, or macular edema. * Inability or unwillingness to provide informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital Universitario Infanta Leonor Madrid Madrid

More Infanta Leonor University Hospital trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07628088 on ClinicalTrials.gov ↗ ← All trials in Spain